Identification of Key Blood Molecular Markers for Immunotherapy
Observational
Observational Model: Cohort, Time Perspective: Prospective
To identify and evaluate the presence of pre-existing immunity related markers in peripheral human blood, to identify patients who may respond to IL-12 immunotherapy
3 years
No
Jeffrey A. Norton
Principal Investigator
Stanford University
United States: Institutional Review Board
VAR0017
NCT00507702
July 2006
July 2012
Name | Location |
---|---|
Stanford University School of Medicine | Stanford, California 94305-5317 |